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Introduction
The adult mammalian CNS is unable to regenerate following axonal injury due to the presence of glial inhibitory environment as well as the lack of a neuronal intrinsic regenerative potential. Research over the past two decades has elucidated several key molecular mechanisms and pathways that limit axonal sprouting and regeneration following CNS axonal injury, including myelin or proteoglycan-dependent inhibitory signalling (Yiu and He, 2006; Giovanni, 2009; Bradke et al., 2012) . More recently, accumulating evidence suggests that the modulation of the neuronal intrinsic potential via the manipulation of selected genes in specific neuronal populations may enhance axonal regeneration in the injured CNS (Park et al., 2008; Moore et al., 2009; Smith et al., 2009; Sun et al., 2011) . More often, these are developmentally regulated pathways that contribute to locking the adult CNS neurons in a non-regenerative mode. Remarkably, deletion of phosphatase and tensin homolog (PTEN) in retinal ganglion cells (RGCs) or in corticospinal tract axons enhances mTOR activity and leads to robust axonal regeneration after optic nerve or corticospinal tract injury, respectively (Park et al., 2008; Liu et al., 2010) , which is further enhanced with conditional co-deletion of SOCS3 (Sun et al., 2011) . Furthermore, modifications of the developmentally regulated neuronal transcriptional program can lead to increased axonal regeneration after optic nerve crush or spinal cord injury as demonstrated by the deletion of kruppel-like factor 4 (KLF4), the overexpression of p300 (encoded by EP300) in RGCs (Moore et al., 2009; Gaub et al., 2011) as well as the overexpression of KLF7 (Blackmore et al., 2012) or retinoic acid receptor beta (RARB) in corticospinal neurons (Puttagunta and Di Giovanni, 2011; .
Ubiquitin ligases and ubiquitin ligase-like proteins, including neuronal precursor cell-expressed developmentally downregulated protein (NEDDs), Smad ubiquitin regulatory factor (SMURFs) and murine double minute 2 and 4 (MDM2 and MDM4), coordinate neuronal morphogenesis and connectivity both during development and after axonal injury. Moreover, they regulate the turnover, localization and activity of a number of proteins and transcription factors involved in the axonal regeneration program, including PTEN, p300, KLFs, Smads, p21 and p53 (Yamada et al., 2013) . Ubiquitin ligases and ubiquitin ligase-like proteins may therefore represent a regulatory hub controlling the regenerative neuronal response following injury. However, their role in axonal regeneration remains unaddressed. Therefore, to functionally rank ubiquitin ligase dependent control of the regeneration programme, we systematically analysed protein networks using the STRING bioinformatic tool including proteins previously described to be involved in axonal regeneration and sprouting in the CNS and the corresponding ubiquitin ligases. This had the goal to identify central protein networks that control the regeneration program that may have positive implications for functional recovery.
This analysis showed that MDM4, in association with MDM2, and p53 constitutes a central regulatory complex, potentially involved in repressing axonal regeneration. The ubiquitin ligase-like MDM4 and MDM2 can form inhibitory protein complexes with at least four key proteins involved in axonal outgrowth: SMAD1/2, p300, p53 (Kadakia et al., 2002; Markey, 2011) . Strikingly, MDM4 and MDM2 expression is developmentally regulated in the retina reaching its maximal levels in adulthood (Vuong et al., 2012) , potentially keeping the post-injury RGC growth program in check. Therefore, MDM4 and MDM2 appear to be strong candidates for limiting axonal regeneration in the CNS, particularly in the injured optic nerve.
We investigated whether disruption of MDM4 and MDM2-dependent regulation would affect the axonal regeneration program. Indeed, we found that MDM4 and MDM2 restrict axonal regeneration after optic nerve crush. In fact, conditional MDM4 deletion in RGCs leads to axonal regeneration and sprouting of RGC axons following optic nerve crush. Additionally, conditional codeletion of MDM4 and its target protein p53 in RGCs after optic nerve crush blocks nerve regeneration elicited by MDM4 deletion alone. Similarly, pharmacological inhibition of the interaction between the MDM4 co-factor MDM2 and p53 via the MDM2/p53 antagonist Nutlin3a also enables regeneration after optic nerve crush, which is abolished in p53 deficient mice. Further, genome-wide gene expression analysis from a pure RGC population after conditional deletion of MDM4 showed enhancement of IGF1R expression suggesting IGF1 signalling as a downstream effector of the MDM4 deletion. Indeed, co-inhibition of MDM4 and IGF1 signalling after optic nerve crush via a specific IGF1R antagonist impairs axonal regeneration, while viral overexpression of IGF1 in the eye enhances it. Finally, we demonstrate that MDM4/2-p53-IGF1 regulation is critical for axonal sprouting and neurological recovery after spinal cord injury. Both conditional deletion of MDM4 and Nutlin-3 delivery after spinal cord dorsal hemisection in mice enhance axonal sprouting of supraspinal descending fibres and functional recovery, which is blocked when IGF1R signalling is inhibited.
Together, this work portrays the MDM4-MDM2/p53-IGF1R axis as a novel molecular target for axonal regeneration and neurological recovery after spinal injury.
Materials and methods

Mice
All experimental procedures were performed according to the animal protocols approved by the Regierungsprä sidium Tü bingen. Mice were housed in a colony maintained at 24 C with a 12 h dark/light cycle and ad libitum food and water. For all surgeries, mice were anaesthetized with xylazine (10 mg/kg of body weight) and ketamine (100 mg/kg of bodyweight), and eye ointment bepanthen was applied to protect corneas during surgery.
Intravitreal injections
For intravitreal injections, pulled glass capillaries attached to a Hamilton syringe via a connector were inserted into the peripheral retina. A volume of vitreal fluid equal to the volume to be injected was removed to avoid intravitreal pressure elevation. The micropipette was deliberately angled in a way to avoid lens injury. Fundoscopic inspection was done after every intravitreal injection to check for any damage to the lens. Animals with lens injury were excluded from the study. For performing the optic nerve injury, the left optic nerve was exposed intraorbitally and crushed for 10 s, 1 mm from the optic disc with forceps (Dumont 5, FST). Care was taken not to injure the ophthalmic artery to avoid retinal ischaemia. Animals with injury to the ophthalmic artery were excluded from the study. For anterograde tracing of the RGC axons, 1 ml cholera subunit B (CtB) conjugated to Alexa Fluor Õ 555 (Invitrogen) was injected intravitreally at least 2 days before sacrificing the mice. Mice were killed with a lethal dose of anaesthesia and transcardially perfused with ice cold 0.1 M phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. Optic nerves and eyes were dissected and post fixed for 1 h at 4 C, before cryoprotecting them with 30% sucrose solution.
AAV-cre in MDM4
f/f mice and Nutlin-3a administration
MDM4
f/f mice were a gift from the J.C.M lab and were produced as described previously (Grier et al., 2006) . Primers used for genotyping of the MDM4 mice were: a-(forward) -5'-ggtgtccttgaacttgctgtgtagaa-3'; b-(exon2 reverse) -5'-ctgggccgaggtggaatgtgatgt-3'; c-(reverse) -5'-tatccagtgtcctcttct ggctt-3'. One microlitre of the adeno-associated virus expressing GFP (AAV GFP) or AAV CreGFP were intravitreally injected in male mice aged postnatal Day 21 and optic nerve crush was performed 14 days later (at postnatal Day 35). Twenty-six days post-optic nerve crush, CtB (Invitrogen, 2mg/ ul) was intravitreally injected in the eye, 2 days before sacrifice by transcardial perfusion (28 days). One microlitre of 100 nm Nutlin-3a or vehicle were intravitreally injected in C57/BL6 (Charles River) male mice aged postnatal Day 35 and optic nerve crush was performed on the same day. Another intravitreal dose of Nutlin-3a was given 7 days post-optic nerve crush. Twenty-six days later, CtB (Invitrogen, 2 mg/ml) was intravitreally injected, and mice were sacrificed by transcardial perfusion 28 days post-optic nerve crush. Both wild-type and p53 À / + mice were used for Nutlin-3a experiments.
Experiments with MDM4 f/f /p53 f/f mice MDM4 f/f were crossed with P53 f/f mice (Strain name: B6.129P2-Trp53tm1Brn/J, Stock Number: 008462, Jackson Labs) to generate MDM4 f/f /p53 f/f mice. The same experimental design including AAV delivery and optic nerve crush was con-
Adeno-associated virus preparation and purification
Details about production of adeno-associated virus 2 (AAV2-GFP/AAV2-CreGFP) has been described elsewhere (Berton et al., 2006; Grieger et al., 2006) . Plasmid vector for AAV-GFP and AAV-CreGFP production were a gift from Dr Eric J. Nestler. Briefly, GFP (control) or an N terminal fusion of GFP to Cre were cloned into a recombinant AAV-2 vector containing the human immediate early cytomegalovirus promoter with a splice donor acceptor sequence and polyadenylation signal from the human-globin gene. Cloning of the AAV-2 vector carrying a human IGF1 cDNA sequence was previously described (PMID 22160392). The vector was produced using a triple-transfection, helper-free method. The final purified virus was stored at À 80 C. The titre was evaluated after infection in HeLa cells and successful infection was also tested in vivo. AAV used were in the range of 1-3 Â 10 13 vector genomes (vg)/ml.
Immunoprecipitation
Whole retinas were collected 72 h after sham or optic nerve crush surgeries and flash frozen in liquid nitrogen. Upon thawing, total proteins were extracted with RIPA lysis buffer (Thermo Inc.) plus protease and phosphatase inhibitors cocktails (Roche). Ten micrograms of protein were diluted in 200 ml of RIPA buffer, and 5 mg of anti-MDM4 antibody (SigmaAldrich) was added and incubated for 1 h on a rotating wheel at room temperature. Mouse normal IgG (Santa Cruz) was used as negative control. The immunocomplexes were collected by adding 40 ml of protein G magnetic beads (Cell Signaling), and incubated for 15 min on a rotating wheel at room temperature. Beads were collected with a magnetic separation rack (Cell Signaling), and washed three times with 500 ml of RIPA buffer. Proteins were then eluted with 10 ml of 4Â loading buffer (Tris HCl 0.25 M, SDS 4%, glycerol 40%, 0.5% Bromphenol blue, 1Â reducing agent) and heated for 5' at 96 C. Beads were separated with the magnetic separation rack, and supernatants onto 4% stacking/10% separating SDS polyacrylamide gels. The proteins were electrophoretically transferred onto nitrocellullose membranes, blocked with PBST + 5% non-fat dried milk, and subsequently MDM4/MDM2-p53-IGF1R in nerve regeneration BRAIN 2015: 138; 1843 -1862 | 1845 incubated overnight at 4 C with antibodies against p53 (rabbit, 1:1000, Santa Cruz) or MDM2 (mouse, 1:1000, Novus). The proteins were detected by horseradish peroxidase-conjugated secondary antibodies (Thermo) and visualized by chemiluminescence reagents provided with the ECL kit (Thermo) and exposure onto hyperfilm (GE Healthcare).
Whole mount retinal staining
After perfusion, uninjured and injured eyes were dissected and post-fixed for 1 h in paraformaldehyde. Flat retinae were plated on a dish in PBS and then stained for Tuj1 to detect surviving RGCs and with DAPI to detect nuclei. The uninjured retinae were used as a control. The retinae were mounted with single coverslips with mounting medium (Dako). At least 10 fields were imaged at Â 25 oil magnification specifically from the retinal ganglion cell layer using Zeiss Apotome. The number of Tuj1 + cells was counted with the help of ImageJ. RGCs were quantified by an observer blind to the treatment. At least 15 high magnification images were taken from different parts of each retina and the total viable RGC number was obtained by multiplying the average number per field of Tuj1 + cells in the ganglion cell layer by the retinal area.
Immunostaining of retina sections
Post-fixed and cryoprotected eyes were snap frozen and then cryosectioned longitudinally (10 mm). Standard immunostaining procedures were followed. Antibody specificity was confirmed by using secondary antibody alone for each staining. 
Retinal ganglion cell densitometry analysis
A high-resolution image was obtained at Â400 magnification using the Zeiss Axioplan Microscope (Axiovert 200, Zeiss Inc.). Images for the same antigen groups were processed with the same exposure time. Assessment of fluorescence intensity was performed using AlphaEaseFC 4.0.1 software by measuring the intensities specifically from retinal ganglion cells. Care was taken that the area analysed for each cell was the same for each set, 100 cells from at least six sections per condition were quantified. The intensity values of each cell were normalized to the 4',6'-diamidino-2-phenylindole signal and mean values of intensities were calculated for each animal (at least three animals per condition) .
Evaluation of optic nerve regenerating axons
Regenerating axons were counted as described previously (Leon et al., 2000; Park et al., 2008) . Longitudinal sections of nerves were mounted and imaged at Â400. Every fourth section and at least four sections per animal were quantified by drawing lines perpendicular to the crush site at a distance of 200, 300, 500, 750, 1000 and 1500 mm from the crush site. CtB + axons between these sections were counted and the cross-sectional width of every nerve was also measured. An observer blind to the treatment counted the regenerating fibres. The number of axons per millimetre was calculated and averaged over all the sections AEad, the total number of axons extending distance d in a nerve having a radius of r, was estimated by summing over all sections having a thickness t (10 mm) AEad = r2 Â [average axons / mm] / t.
Cerebellar granule neuron culture
Cerebellar granule neurons were prepared from cerebella of post-natal Day 7 MDM4 f/f mice as described previously (Gaub et al., 2010; Bradke et al., 2012) . Briefly, the minced cerebella were incubated for 15 min at 37 C in an ionic medium with 0.025% trypsin and 0.05% DNase I (Sigma). Then trypsin inhibitor (0.04%, Sigma) was added followed by centrifugation. The pellet was triturated, centrifuged and suspended in the growth medium [basal Eagle's medium supplemented with 10% bovine calf serum, 25 mM KCl, 4 mM glutamine and gentamycin (100 ng/ml)]. Cells were plated at a density of 10 5 cells on PDL/myelin (4 mg/cm 2 ) coated plates followed by infection with adenovirus 5 (AV5)-GFP/AV5-Cre (2 Â 10 10 vg/ml). Cells were then fixed with 4% paraformaldehyde 24 h later followed by staining with anti-Tuj1 and antiCre. At least 100 single transduced cells per condition (n = 4) were traced manually with Neurolucida software.
Viral injections into the sensorimotor cortex
Four-week-old MDM4 f/f mice were anaesthetized with ketamine and xylazine and then placed on a stereotactic frame. To infect layer V neurons, AAV1-GFP or AAV1-CreGFP under CMV promoter were injected with a 5 ml Hamilton syringe in the right sensorimotor cortex 5 weeks before spinal cord injury. The viruses were injected after craniotomy in a total of four sites [0.8 ml/site of AAV1-GFP or AAV1-CreGFP (3.1 Â 10 9 vg/ml) (SignaGen)]. The coordinates used were 1.0 mm lateral, 0.6 mm deep, and + 0.5, À0.2, À 0.7, and À 1 mm with respect to bregma (Steward et al., 2008 Retinal ganglion cell culture Dissociated retinal ganglion cell culture has been described previously . Briefly, post-natal Day 7 eyes were dissected, and retinae were incubated in Dulbecco's modified Eagle's medium with Papain (Worthington) and L-cysteine (Sigma) for 40 min. After incubation, retinae were dissociated in Dulbecco's modified Eagle's medium with B27 (Life Technologies) and penicillin/streptomycin (Sigma). Cells were plates at a density of 10 6 cells per 2 cm 2 . Plated cells were immediately infected with AV-GFP and AV-Cre at 100 multiplicity of infection. Following incubation, cells were fixed with 4% paraformaldehyde for 20 min. Cells were then blocked with 8% bovine serum albumin, 0.1% Triton TM X-100 in PBS and finally incubated with the primary antibodies overnight at 4 C: mouse anti-Tuj1 (1:1000, Promega). Cells were then washed with PBS and incubated with appropriate secondary antibodies (1:1000, Invitrogen) for 1 h at room temperature. At least 10 images taken at Â200 magnification with Axioplan inverted microscope (Zeiss) were automated analysed for neurite outgrowth with ImageJ, NeuriteTrace plugin.
Immunoblotting
For immunoblotting, entire retinae were collected 6 h after Nutlin-3a injection and optic nerve crush and flash frozen or 72 h after sham surgery or optic nerve crush. For spinal cord tissue, spinal cord segments corresponding to the injury site (3 mm rostral and 3 mm caudal to the lesion) were harvested and flesh frozen in liquid nitrogen. On thawing, proteins were extracted with RIPA buffer (50 mMTris., 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS, 0.1 mM PMSF, 1 Â Protease inhibitor (Roche), 1Â PhosphoStop (Roche). A portion of the lysate (30-50 mg of protein) was then fractionated by SDS-polyacrylamide gel electrophoresis, and the separated proteins were transferred to a nitrocellulose membrane and following blocking, probed for different antigens, as follows: rabbit anti-p53 (1:1000, Santa-Cruz), mouse anti-MDM4 (1:1000, Sigma), rabbit anti-MDM2 (1:1000, Novus); rabbit anti-acetylated p53 (lysine 373) (1:500, Millipore), rabbit anticleaved caspase-3 (1:1000, Cell Signaling) or rabbit anti-p21 (1:500, Abcam). Mouse anti-b-actin (1:5000, Sigma) was used as a loading and transfer control. Immune complexes were detected with appropriate secondary antibodies (goat antirabbit IgG, goat anti-mouse IgG, label with horseradish peroxidase (Thermo Scientific) and chemiluminescence reagents (Pierce ECL Western blotting Substrate).
Retrograde labelling of retinal ganglion cells for FACS and Affymetrix gene expression analysis
DiI (Molecular Probes, Invitrogen, 2% in dimethyl formamide) was injected in the superior colliculus of post-natal Day 28 mice. Anaesthetized mice were placed in a stereotaxic holder and $2 ml DiI was then injected directly into the superficial superior colliculus (4.5 mm caudal to Bregma, 0.5 mm lateral to sagittal suture and 1-2 mm deep to brain surface) using a 10ml gas tight syringe (Hamilton) connected to an automated nano-injector. Seven days after superior colliculus injection, the optic nerve crush was performed. Three days (72 h) after crush, retinae were dissected and incubated in digestion solution (20 U/ml papain, Worthington; 1 mM L-cysteine HCl; 0.004% DNase; 0.5 mM EDTA in Neurobasal Õ ) for 25-40 min at 37 C, with gentle shaking every 5 min. Digestion was stopped by adding Ovomucoid solution before trituration. Retinae were then passed through a 40 mm filter. The obtained suspensions of the retinae were then processed using fluorescence-activated cell sorting (FACS). For microarray, total RNA was isolated from the FACS sorted RGCs using PureLink RNA micro kit (Invitrogen) according to manufacturer's instructions. Affymetrix Mouse Genome 430 2.0 Array from triplicate samples was performed at the Microarray Genechip Facility at Universitä tsklinikum, Tü bingen. Data processing and analysis was performed according to standard procedures (GC-RMA, RMA, MAS5). Genes differentially expressed were selected based upon a 2-fold change cut-off and significant statistical difference (ANOVA with Bonferroni correction). The microarray data analysis was carried out by Ingenuity Pathway Analysis software (Ingenuity System Inc). Cluster analysis for selected probe sets was performed in R 3.0.1. Signal intensities were scaled and centred and the distance between two expression profiles was calculated using Euclidian distance measure. Hierarchical cluster analysis was performed with average linkage for genes. Heat maps were generated with the Bioconductor package gplots.
Drugs
Nutlin-3a (Cayman) was diluted in 8.6% ethanol in DPBS (vehicle). Before use in osmotic mini-pumps. Picropodophyllin (Medkoo Biosciences) was diluted in 1:10 dimethyl sulphoxide:cottonseed oil (vehicle). The oil was dry-heat sterilized at 150 C for 1 h, before use for i.p. (intraperitoneal) delivery.
Spinal cord injury surgical procedure, BDA tracing and postoperative care
The experimental procedure followed for spinal cord injury has been described previously (Floriddia et al., 2012) . Briefly, anaesthetized wild-type or Mdm4 f/f mice (ketamine/xylazine) were kept on a heating pad to maintain the body temperature at 37 C during the whole procedure. An incision was made on the thoracic area after shaving and cleaning with Softasep Õ N (Braun). Muscle tissue right below the incision was dissected to expose laminae T8-T10. A dorsal hemisection at T9 until the central canal was performed with a microknife (FST). To ensure that the lesion was complete, the microknife was passed throughout the dorsal part of the spinal cord several times. This kind of injury damages the dorsal and lateral corticospinal tract, the dorsal columns, the rubrospinal, the dorsal and lateral raphe-spinal, and part of the reticulospinal tracts.
For spinal surgeries with Nutlin-3 delivery by osmotic minipumps (Alzet 2002) 12-week-old C57BL/6 mice (Charles River, Germany) mice were used. A customized 32 G-polyethylene IT catheter (ReCathCo) was placed subdurally until T9. Once placed, the caudal tip of the catheter was glued to the T12 bone with a drop of cyanoacrylate glue (Cyano Veneer, Hager&Werken). The pump was placed in the subcutaneous space on the back of the animal caudal to the surgical incision. All the surgical procedures were performed in an unbiased blind fashion, i.e. the surgeon did not know the content of the pumps (vehicle versus drug). After 2 weeks pumps were removed under 2% isoflurane/0.8% O 2 and mice were injected with the non-steroidal anti-inflammatory carprofen (Carprieve, Norbrook, 5 mg/kg subcutaneously). The pump was freed from the subcutaneous tissue and removed. The IT catheter, however, was left in place to avoid a secondary injury to the spinal cord. The skin was closed with suture clips. During the surgical procedure, animals were kept warm at 37 C. After surgery, mice were placed back in their cages and warmed up with an infrared light to prevent hypothermia. Mice underwent daily check for general health, mobility within the cage, wounds, swelling, infections, or autophagy of the toes throughout the experiment. They were injected subcutaneously with 1 ml of 0.9% saline twice daily for 3 days and once daily from Days 4 to 7 after surgery. Pain was managed with injections of 0.05-0.1 mg/kg subcutaneous buprenorphine twice daily (12/12 h) for the first 3 days after the spinal cord injury surgery and 5 mg/kg/day subcutaneous of carprofen for Days 4-7. To prevent urinary infection, enrofloxacin was injected at 5 mg/kg once daily in the first 5 days after surgery. If the animal developed signs of urinary infection in the chronic phase, it received enrofloxacin 10 mg/kg/day subcutaneously for 14 days, and 1 ml of 0.9% saline solution subcutaneously daily until the urine was clear. Animals also received Nutrical as food supplement after the spinal cord injury surgery. Bladders were manually expressed twice daily until needed. Ten to 14 days before sacrifice, the animals were injected with 1.4 ml of a 10% (w/v) solution of BDA (fluorescent biotin dextran tetramethylrhodamine; 10 000 MW, Molecular Probes, 10% w/v in PBS) into four injection sites of the right sensorimotor cortex of the hind limb region to trace the corticospinal tract as previously described (Simonen et al., 2003) .
Quantification of corticospinal tract sprouting
Two weeks following tracer injection mice were perfused transcardially with 0.1 M PBS, pH 7.4, and 4% paraformaldehyde in PBS, pH 7.4 under deep anaesthesia. For each animal, at least three consecutive most medial parasagittal cryosections (18 mm) using the central canal as landmark were chosen and analysed with the software Stereo-Investigator 7 (MBF Bioscience) to count axons and sprouts. The quantification of the sprouting index of the dorsomedial corticospinal tract was performed proximal to the lesion site at rostral and caudal level. For each section, the BDA-labelled sprouts and axons were counted live. The sum of the total number of labelled axons and axon sprouts was normalized to the total number of labelled axons above the lesion site counted in all the analysed sections for each animal, obtaining an inter-animal comparable ratio considering the individual tracing variability (Schnell and Schwab, 1993; Steward et al., 2008) . Sprouts and regrowing fibres were defined following the anatomical reported criteria (Joosten and Bar, 1999; Steward et al., 2003; Hill et al., 2004; Erturk et al., 2007) . Cords showing spared fibres were excluded by monitoring BDA labelling in coronal sections from 15 mm below the lesion site.
Immunohistochemistry of brain and spinal cord sections
Animals were intracardially perfused with cold 0.1 M PBS, pH 7.4, followed by fixation with cold 4% paraformaldehyde in 0.1 M PBS, pH 7.4. The spinal cords and brains were dissected and post-fixed with 4% paraformaldehyde for 2 h in ice, then cryoprotected in 30% saccharose and kept at 4 C. After 5-7 days, the tissues were frozen in liquid nitrogen and kept at À 80 C until sectioning. The spinal cords and the brains were embedded in Tissue-Tek O.C.T. compound. The cords were sectioned in the sagittal plane at 18 mm thickness, including the injury site. Coronal sections of the cords 1.0 cm rostral and 1.5 cm caudal to the injury site were also included. Brains were sectioned at 40 mm in the coronal plane and the sections were collected in cryoprotectant solution. The tissues were kept at À20 C until staining. For all the stainings performed, the antibody specificity was tested by incubating samples only with the secondary antibody. Primary antibodies for spinal cord sections: anti-fibronectin (1:500, Sigma), anti-GFAP (1:500, Millipore). Coronal sections from brains (40 mm) were processed and stained in free-floating to detect GFP signal in the sensorimotor cortex. GFP signal was also enhanced using chicken anti-GFP antibody (1:500, Abcam). Sections were also stained with anti-Ctip2 antibody (1:500, Abcam) to mark layer V neurons.
Immunohistochemistry anti-fibronectin allowed visualizingation of the core of the lesion site. Immunohistochemistry anti-GFAP allowed defining the size of the spinal lesions in all of the experiments performed including treatment versus vehicle. The GFAP-positive immunolabelling delimiting the lesion site was measured in triplicate sections centred around the central canal for each cord. The lesion size was comparable between experimental and control conditions, therefore not affecting the assessment of axonal sprouting.
For 5-HT immunostaining we followed a protocol as previously described (Floriddia et al., 2012) . Briefly, spinal cord sections were post-fixed in 0.1% glutaraldehyde in 4% paraformaldehyde. Then quenched with ethanol peroxide and transferred to 0.2% sodium borohydride. They underwent antigen retrieval in 0.1 M citrate buffer, pH 4.5, and microwave irradiation at 98 C for 2 min. The sections were incubated with rabbit anti-5-HT (1:8000, ImmunoStar) in 4% normal goat serum in 0.3% Tris-buffered saline-Triton TM X-100 for 4 days at 4 C. After that, the sections were further blocked in avidin and biotin (avidin-biotin blocking kit, Vector Labs), then were incubated in biotinylated goat anti-rabbit antibody (1:200, Vector Labs) in 2% normal goat serum in 0.3% Trisbuffered saline-Triton TM X-100 followed by incubation in ABC elite complex (Vector Labs). The signal was further amplified by incubation in biotinylated tyramide and revealed with diaminobenzidine tetrahydrochloride (Vector Labs). The sections were dehydrated and coverslipped. Measurements were conducted blind to the experimental conditions.
5-HT sprouting
Behavioural assessments
Mice were gently handled daily for five to seven sessions. Thereafter they were acclimatized to the Basso Mouse Scale (Basso et al., 2006) open field platform and to the grid walk apparatus daily for another five to seven sessions. The investigators that participated in the behavioural ratings were blind to the pump content (Nutlin-3a or vehicle) or to the solution the animals were being injected intraperitoneally (picropodophyllin or vehicle). Only animals with a histological proof of hemisection until the central canal, excluding the ones with occurrence of spared fibres below the lesion or with a total hemisection, were taken into account.
Basso Mouse Scale
Briefly, a mouse walked on the platform for 4 min during which its motor behaviour was rated by two investigators in terms of ankle movement, paw placement, stepping and paw position of the hindlimbs, coordination, trunk stability and tail position. The Basso Mouse Scale main score and subscore were given. Animals were tested 1 day before, then 1, 3, 7, 14, 21, 28 and 35 days after injury.
Grid walk
The grid walk consists of a 50 cm Â 3 cm metal grid placed between two vertical 40 cm high wood blocks. The metal mesh is formed by 1 cm Â 1 cm spaces. Only animals able to frequent or consistently step (Basso Mouse Scale 5 5) were also tested on the grid walk. The mice were video recorded for 3 min while running on the grid in both directions. The videos were later analysed by a blind investigator, who counted the number of missteps. A misstep occurs when the animal fails to place the paw on the grid and the paw slips down in the 1 cm Â 1 cm space. Only animals that had at least three compliant runs were considered for statistical analysis. A compliant run was defined as a run comprising at least g of the grid length in consistent speed. The animals were tested in the grid walk 1 day before the injury and 14, 21, 28 and 35 days afterwards.
To ensure that surgical procedures did not interfere with the behavioural assessments, animals were tested in the Basso Mouse Scale and grid walk in the same day but before the pump was removed (14 days post-injury) and before the tracer was injected (35 days post-injury).
Experiments were performed by the surgeons blinded to the content of either the minipumps or the syringes containing virus or drug. Another researcher organized the groups at random allowing for equal group sizes on each day of surgery; however, the order and treatment were withheld from both the surgeons and the researchers performing behavioural and histological analysis. The treatment order was randomized at the level of the animal such that within a day post-injury, drug treated or control treated animals were interspersed at random. Animals were excluded from analysis in the case of spared fibres (see above) or when we observed a total transection with the fibronectin positive scar spanning the entire depth of the spinal cord. These animals were rejected from analysis by someone blinded to their treatment allocation. A detail description of the experimental designs can be found in Supplementary Tables 3 and 4 
STRING bioinformatics analysis
STRING functional protein interaction analysis online tool based upon the work by Jensen et al. (2009) was used to identify cluster of axonal regeneration regulatory protein central to the whole protein network. Fifteen regulatory protein networks for genes involved in the axonal regeneration program within the CNS were included in the analysis. They include: STAT3, SMAD1, SMAD2, KLF4, KLF7, KLF9, jun, p53, p300, PTEN, SOCS1, SOCS3, RARB, CREB and SOX11. The interactions include direct (physical) and indirect (functional) association. All of the interactions reported have P-values 50.001, while K-means based clustering was used.
Results
MDM4 conditional deletion stimulates optic nerve regeneration and corticospinal tract axonal sprouting
Initially, we performed a protein network analysis with STRING network and protein interaction algorithms to determine whether ubiquitin ligases and ubiquitin-like ligases may be linked to known transcriptional and protein synthesis regulators of axonal regeneration in CNS axons (see 'Materials and methods' section for detail). Given their central positioning in the protein network, we identified a protein complex composed of MDM4-MDM2 and p53 potentially restricting the regenerative program ( Supplementary Fig. 1A ). To examine our hypothesis in an in vivo model of non-regenerating axons after injury, we used the optic nerve crush method in mice, where the injured optic nerve does not regenerate. First, we established by co-immunoprecipitation experiments that MDM4, MDM2 and p53 form a protein complex in the retina both before and after optic nerve crush ( Supplementary Fig. 1B) . Importantly, these three proteins are highly expressed in retinal ganglia cells ( Supplementary  Fig. 2 ). Next, we asked whether disruption of this complex would enhance axonal regeneration. To this end, we performed conditional deletion of MDM4 specifically in RGCs by intravitreal injection of AAV2-CreGFP virus in MDM4 f/f mice 2 weeks before optic nerve crush, while an AAV2-GFP vector was used as a control (Fig. 1) . AAV2 infects RGCs rather efficiently and specifically due to the physical proximity ( Supplementary Fig. 3A) , although $5-10% of other neuronal populations can also be infected.
Following AAV2-cre mediated infection ( Supplementary Fig. 3A ) and conditional deletion we could confirm a strong reduction of MDM4 expression in infected cells (Supplementary Fig. 3B ). Additionally, AAV-cre mediated genetic deletion of MDM4 in primary retinal cells determined by semi-quantitative PCR confirmed MDM4 deletion ( Supplementary Fig. 3C ). Significantly, MDM4 deletion promoted axonal regeneration of the optic nerve as measured 28 days after optic nerve crush (Fig. 1) ; however, it did not affect RGC survival (Fig. 1) .
To confirm the generalization of this regenerative phenotype to another clinically relevant CNS fibre tract, we investigated whether MDM4 conditional deletion may enhance axonal sprouting and regeneration of the corticospinal tract after spinal cord injury. To this end, we performed AAV1-cre-mediated MDM4 conditional deletion in the sensorimotor cortex of MDM4 f/f mice ( Fig. 2A and Supplementary Fig. 4A and B) and subsequently performed a spinal thoracic T9 dorsal hemisection, which severs the corticospinal tract in mice. An AAV1-GFP virus was again used as a control. It is important to note that GFP was found highly expressed in the sensorimotor cortex including in layer V neurons (Supplementary Fig. 4C ). In line with the data from the optic nerve, we found significant axonal sprouting and regeneration after MDM4 conditional deletion while control-infected mice displayed the typical collapse of the corticospinal tract before reaching the lesion site (Fig. 2C and D and Supplementary Fig. 5 ). Lack of BDA tracing below the lesion site allowed exclusion of the presence of spared corticospinal tract fibres (Fig. 2E) .
In support of the specificity of the in vivo axonal regeneration findings, we investigated neurite outgrowth in cultured RGCs and cerebellar granule neurons on both outgrowth permissive and myelin inhibitory conditions. AV-cre or AV-GFP control viruses were employed to infect RGCs or cerebellar granule neuron at the time of plating on poly-D-lysine or myelin and neurite outgrowth was analysed at 72 h and 24 h, respectively. Results showed that MDM4 deletion enhances neurite outgrowth in both RGCs and cerebellar granule neurons on both permissive and inhibitory substrates ( Supplementary Fig. 6 ).
Together, these data suggest that MDM4 conditional deletion significantly lifts the CNS regenerative block thus enhancing axonal regeneration and sprouting after optic nerve and spinal injury in sensory and motor neurons.
MDM4 conditional deletion enhances optic nerve regeneration via p53 and is phenocopied by inhibition of the MDM2/p53 interaction
To gain mechanistic insight into the regenerative phenotype observed with MDM4 conditional deletion, we investigated the role of the MDM4 associated proteins, p53 and MDM2. MDM4 typically keeps p53 transactivation under check (Marine and Jochemsen, 2005) , as supported by our findings in primary neurons where conditional deletion of MDM4 ( Supplementary Fig. 7A ) enhances p53-dependent gene targets, including axon growth associated genes ( Supplementary Fig. 7B ). Therefore, we hypothesized that MDM4 deletion could enhance the regeneration program via p53 transactivation. To this end, we investigated whether double conditional deletion of MDM4 and p53 would block the regenerative phenotype observed with MDM4 deletion. We performed AAV2-cre conditional deletion of MDM4 and p53 in RGCs simultaneously in double MDM4
f/f /p53 f/f mice ( Fig. 1 ) and found that this abolished axonal regeneration induced by MDM4 deletion alone as the number of axons past the crush site were now similar to AAV2-GFP control infected mice (Fig. 1) . This demonstrates that p53 is required for MDM4-dependent axonal regeneration. Next, we further explored the central role of ubiquitin ligase related signalling in this regenerative paradigm. Thus, we asked whether modulation of the MDM4 binding protein and ubiquitin ligase MDM2, also expressed in RGCs ( Supplementary Fig. 2E and F), would be phenocopying axonal regeneration as seen upon deletion of MDM4. Given that MDM2 controls p53 protein levels by ubiquitination and proteasome degradation, we inhibited MDM2/p53 interaction by intravitreous injection of the well-characterized small molecule MDM2/p53 antagonist Nutlin-3a (Vassilev et al., 2004) . Importantly, Nutlin-3a (100 nM) delivery at the time of optic nerve crush and 7 days later (Fig. 3A) promoted axonal regeneration of the optic nerve to a similar extent as MDM4 deletion without affecting the survival of RGCs 28 days after crush (Fig. 3B , C, E and F). Administration of Nutlin-3a enhanced p53 protein levels in the retina as expected (Fig. 3G) . To investigate by a genetic approach whether MDM2/p53 inhibition promotes axonal regeneration specifically via p53, we performed an analogous set of Nutlin-3a experiments, but in p53 À / + mice that typically retain only 25% of p53 expression; however, do not display aberrant cell metabolism as opposed to p53 À / À mice (Boehme and Blattner, 2009 ). This would also address whether a 'minimum' threshold p53 expression level is required for axonal regeneration similar to the p53 dosage effect found in cancer (Boehme and Blattner, 2009 ). Data analysis revealed that axonal regeneration of the optic nerve after crush was significantly reduced in Nutlin-3a p53
À / + mice as compared to wild-type ( Fig. 3B  and D) , further supporting the overall model that the observed regeneration after either deletion of MDM4 or inhibition of MDM2 is dependent upon p53 transactivation. Indeed, Nutlin-3a delivery in primary neurons enhanced p53 transactivation as shown by quantitative RT-PCR ( Supplementary Fig. 8A ), without promoting apoptosis ( Supplementary Fig. 8B ). Genes included as p53-target were previously identified as predicted (promoter analysis correlating with gene expression following p53 modulation) or fully experimentally confirmed p53 targets (including with chromatin immunoprecipitation assays) (Tedeschi et al., 2009; Gaub et al., 2011) .
Optic nerve axonal regeneration after conditional MDM4 deletion relies upon the IGF1R pathway
The data thus far point to a model where disruption of the MDM4-MDM2/p53 inhibitory protein complex triggers axonal regeneration after optic nerve crush. To explore directly in vivo in RGCs whether disruption of this complex via MDM4 deletion would affect the gene expression program supporting the regenerative phenotype, we 
MDM4/MDM2-p53-IGF1R in nerve regeneration
performed Affymetrix-based genome wide gene expression arrays from FACS isolated RGCs after optic nerve crush. DiI-positive retrogradely traced RGCs were sorted 3 days following optic nerve crush from MDM4 f/f mice that underwent either AAV2-creGFP or AAV2-GFP control intravitreous injections (Fig. 4A and B) . Functional data analysis of statistically significant differentially regulated transcripts was performed with the Ingenuity pathway analysis platform. Unsupervised hierarchical clustering of the gene expression data showed a clear separation of the gene expression profiles between AAV2-cre and AAV2-GFP cells (Fig. 4C) . Additionally, Ingenuity pathway analysis revealed that conditional MDM4 deletion was associated with a number of receptor-dependent signalling cascades involved in cell growth and metabolism (Fig.  4D , Table 1 , and Supplementary Tables 1 and 2 ). Highly ranked differentially regulated pathways were p53 and the related GADD45 cascades (Fig. 4D and Supplementary Table 2), supporting our model. Of special interest was the MDM4-deletion dependent activation of insulin and insulin receptor signalling pathways via overexpression of IGF1R, as insulin-dependent pathways have a key role in cell growth and are highly neurotrophic. Careful analysis of IGF1R protein expression in RGCs revealed that in most cells where MDM4 deletion occurred, IGF1R levels were particularly elevated, whereas in control AAV-GFP positive RGCs, IGF1R was lower ( Fig 6E) . Next, we asked whether the IGF1R pathway might be critical for the downstream regenerative signalling elicited by conditional deletion of MDM4. Therefore, we decided to inhibit IGF1R signalling after MDM4 deletion and optic nerve crush. We chose to use picropodophyllin, a highly selective and potent inhibitor of IGF1R (IC 50 = 6 nM) that efficiently blocks IGF1R activity and expression in vivo without noticeable toxicity. In preparation for the in vivo experiment, we performed a dose response analysis of picropodophyllin in primary neurons in permissive growth conditions and monitored toxicity (active cleaved caspase 3-positive neurons) and neurite outgrowth. This allowed identifying a dose between 10 nM and 1 mM that efficiently inhibited neuronal outgrowth without resulting in significant toxicity ( Supplementary Fig. 9A and B) . After AAV2-cre MDM4 conditional deletion in RGCs of MDM4 f/f mice (Fig. 5A ), picropodophyllin 1 mM was delivered both intravitreous and at the site of the nerve crush at the time of optic nerve crush and optic nerve regeneration was evaluated at 28 days post-injury. Indeed, picropodophyllin delivery strongly reduced the expression of IGF1R (Fig. 5B) and drastically inhibited optic nerve regeneration induced by MDM4 deletion, without affecting RGC survival (Fig. 5C-F) .
In line with IGF1R loss of function, overexpression of IGF1 in the eye (Fig. 6A and B) led to enhanced axonal regeneration ( Fig. 6C and D) , whereas it did not affect RGC survival (Fig. 6E and F) . Together, these data support a role for IGF1 signalling in axonal regeneration downstream of MDM4.
Pharmacological modulation of MDM2/p53/IGF1R axis enhances axonal sprouting and functional recovery after spinal cord injury Next, we decided to investigate whether pharmacological modulation of the MDM2/p53/IGF1R axis would enhance axonal sprouting and functional recovery after spinal cord injury. To this end, we continuously delivered intrathecally the small molecule Nutlin-3 via an osmotic minipump at the time of spinal cord injury in proximity of the injury site (T9 dorsal hemisection) for 14 days and performed locomotor behavioural tests for 5 weeks post-injury. Importantly, Nutlin-3 triggered the expression of active p53 and of the well-characterized p53 target gene p21 (now known as CDKN1A), while it did not enhance active caspase 3, suggesting lack of Nutlin-3 dependent cell death ( Supplementary Fig. 10 ) After sacrifice, we measured axonal regeneration and sprouting of supraspinal descending fibres including the BDA labelled corticospinal tract and the 5-HT raphe-spinal projections, whose sprouting highly correlates with locomotor recovery (Trakhtenberg and Goldberg, 2012) . Indeed Nutlin-3 delivery induced significant functional recovery as compared to vehicle as measured by open field Basso Mouse Scale scores and subscores as well as by assessing locomotion ability on a Gridwalk (Fig. 7 and Supplementary Videos 1 and 2). This was paralleled by enhancement in corticospinal tract sprouting ( Fig. 7 and Supplementary Fig. 11 ) and most remarkably in 5-HT fibre sprouting below the lesion site (Fig. 8) . No spared fibres below the lesion were found in all the cords included in the analysis. Finally, inhibition of IGF1R signalling via intraperitoneal delivery of picropodophyllin together with Nutlin-3 mini-pump administration strongly reduced sprouting of 5-HT tracts (Fig. 8) as well as Nutlin-3 dependent functional recovery (Fig. 8) . Together these data support a novel role for MDM2/p53/ IGF1 axis in axonal sprouting and functional recovery after spinal cord injury.
Discussion
The reasons underlying the lack of a neuronal intrinsic regenerative potential after CNS axonal injury seem to be found in an inhibitory molecular network, which either exists prior to axonal injury or is elicited by it. The present work defines MDM4-MDM2/p53 as a protein complex restricting axonal sprouting and regeneration, whose disruption activates p53 and the axonal regenerative program via IGF1 signalling. Although the effect of MDM4 deletion upon functional recovery after spinal cord injury has not been tested, inhibition of MDM2/p53 interaction led to MDM4/MDM2-p53-IGF1R in nerve regeneration significant functional recovery after spinal injury. Therefore, the discovery of the MDM4-MDM2/p53-IGF1 axis clarifies a cause for failed regeneration and provides a target for regenerative therapy after nerve and spinal injury. MDM4 was first identified as a p53 binding protein in selected cancers where it inhibits p53 transcriptional activity thus promoting tumour progression (Markey, 2011) . Similarly, MDM4 regulates cell cycle, survival and apoptosis by forming an inhibitory complex with a selected set of proteins that include MDM2, ASPP1, ASPP2, p300, SMAD1 and SMAD2 (Sabbatini and McCormick, 2002; Wade et al., 2010; Gaub et al., 2011) . However, a role for MDM4 and MDM2 in axonal regrowth has, until now, been missing. Here, we show that conditional deletion of MDM4 enhances axonal regeneration and sprouting after optic nerve crush and spinal cord injury, respectively and co-deletion of p53 significantly diminishes the MDM4-deletion dependent regenerative phenotype, while inhibition of MDM2/p53 interaction mimics it. Moreover, pharmacological small molecule mediated disruption of the MDM2/ p53 complex enhances axonal sprouting of long spinal descending tracts and promotes significant neurological recovery after spinal cord injury.
We have recently shown that the tumour suppressor and transcription factor p53 is required for neurite outgrowth, axonal sprouting and regeneration both after facial nerve injury and spinal cord hemisection in mice (Di Giovanni et al., 2006; Tedeschi and Di Giovanni, 2009; Tedeschi et al., 2009a, b; Floriddia et al., 2012) . Specifically, transcriptionally active acetylated p53 at K372-3-82 and the acetyltransferases CBP/p300 and P/ CAF form a transcriptional complex that occupies promoters of selected pro-regenerative genes, driving neurite outgrowth (Di Giovanni et al., 2006; Tedeschi et al., 2009) . p53 integrates numerous stress signals including following axonal injury and it undergoes tight regulation of its protein levels, subcellular localization and of its transcriptional activity by several factors, including the welldefined negatively regulators MDM2 and MDM4 (Lavin and Gueven, 2006) . MDM2, an E3 ubiquitin ligase, targets p53 for degradation via the ubiquitin proteasome pathway and negatively regulates p53 cytoplasmic-nuclear shuttling (Toledo and Wahl, 2007) . MDM4, although structurally similar to MDM2, is devoid of ubiquitin ligase activity, and rather regulates with MDM2 p53 cytoplasmic-nuclear shuttling and it occupies the p53 transcriptional activation domain thereby inhibiting p53 transactivation (Toledo and Wahl, 2007) . MDM4 prevents p53 nuclear translocation in association with MDM2 and competes with the acetyltransferases CBP and p300 for binding to lysines on p53 C-terminus, overall hindering p53 transcriptional activity.
Given the pro-neurite outgrowth and axon regeneration function of the MDM4 interacting proteins p300 and Smads (Zou et al., 2009; Gaub et al., 2011; Parikh et al., 2011) , it is plausible that p300-dependent acetylation of regenerative promoters as well as TGFb-Smad signalling may also contribute to axonal regeneration induced by MDM4 deletion. In support of this, we have recently shown that p300 acetylates p53 in RGCs after optic nerve crush during p300-dependent axonal regeneration, supporting the presence of this signalling network during axonal regeneration . Given the axon regenerative/sprouting function of p21 (Tanaka et al., 2004) , the previously described inhibitory MDM4 protein complex with p21 (Markey, 2011) , which is also a classical p53-target gene, may also play a role in axonal regeneration. Interestingly, we found that MDM4 deletion in primary neurons enhanced p21 gene expression levels along with other classical regeneration associated genes, supporting the inhibitory role for MDM4 in repressing the regenerative gene expression program. An extranuclear and non-transcriptional role for p53 in growth cone remodelling and axonal outgrowth has also been described. For example, inhibition of p53 phosphorylation causes growth cone collapse in primary neurons via RhoA kinase activation (Qin et al., 2009) . Additionally, when active phosphorylated p53 is truncated by calpain activity following semaphorin 3 A-induced growth cone collapse, it results in cytoskeleton reorganization by activating Rho Kinase (ROCK), therefore enhancing growth cone retraction (Qin et al., 2010) . This highlights how inhibition of MDM2 and MDM4 may also promote axonal outgrowth via p53 localization and activation in axons and at the growth cone. Further, genome-wide analysis from FACS sorted RGCs after optic nerve crush revealed that MDM4 conditional deletion was associated with the enhancement of transcripts involved in cytoskeleton remodelling, axonal development and signalling, including genes involved in neuronal maturation (Table 1 ). This pattern of gene expression changes suggests that MDM4 deletion modulates developmentally regulated pathways, which may support axonal regrowth.
Additionally, here we show that IGF1R signalling is required for axonal regeneration of the crushed optic nerve induced by MDM4 deletion and it is likely downstream of the transcriptional complex formed by MDM4-p53/MDM2. The best-characterized IGF1R targets include PI3K and JAK/STAT3, which are typically activated by IGF1R (Staerk et al., 2005; Serra et al., 2007; Subbiah et al., 2011; Kim et al., 2012) . Both PI3K and JAK/ STAT3 activation depends upon the phosphorylation status that has been shown to be necessary to promote axonal regeneration following deletion of PTEN or after JAK binding to IL6, respectively (Cao et al., 2006 et al., 2008) . This suggests a likely cross-talk between the MDM4-MDM2/p53-IGF1 signalling and these regenerative pathways, further supporting our findings. Last but not least, our work shows that MDM2/p53 inhibition via Nutlin-3, a small molecule, significantly enhances axonal sprouting of corticospinal tract and of 5-HT descending fibre tracts as well as functional recovery after spinal cord injury. Importantly, inhibition of IGF1R signalling via picropodophyllin blocks axonal sprouting of the functionally limiting 5-HT tracts as well as Nutlin-3 dependent neurological recovery. This suggests MDM2/ p53-IGF1 as a novel regenerative pathway following nerve and spinal injury, including the opportunity of a novel therapeutic target for recovery after spinal trauma.
Park
Given that pharmacological antagonism of MDM2-p53 interaction including with Nutlins have been shown to induce tumour suppression and are currently being explored in the clinic for cancer treatment and have been shown to be safe (Brown et al., 2009) , they may represent viable options for neuroregenerative therapy in the short-term. The recent discovery of specific small molecule inhibitors of MDM4 (Reed et al., 2010; Vogel et al., 2012) , which are still awaiting confirmation in multiple studies, may also expand our regenerative therapeutic options. scholarship (L.Z.). Start-up funds-Division of Brain Sciences, Imperial College London (S.D.G.). The research was supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (S.D.G.). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
